Authors: LEPPIG KA DISTECHE CM OPHEIM KE PAGON RA HUDGINS L

Citation: Ka. Leppig et al., FACTORS FAVORING THE DIAGNOSTIC YIELD OF 2ND CYTOGENETIC STUDIES FOR CONSTITUTIONAL ABNORMALITIES, American journal of human genetics, 61(4), 1997, pp. 153-153

Authors: KRADJAN WA TAKEUCHI KY OPHEIM KE WOOD FC

Citation: Wa. Kradjan et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF GLIPIZIDE AFTER ONCE-DAILY AND DIVIDED DOSES, Pharmacotherapy, 15(4), 1995, pp. 465-471

Authors: OPHEIM KE BRITTINGHAM A CHAPMAN D NORWOOD TH

Citation: Ke. Opheim et al., BALANCED RECIPROCAL TRANSLOCATION MOSAICISM - HOW FREQUENT, American journal of medical genetics, 57(4), 1995, pp. 601-604

Authors: LEPPIG KA OPHEIM KE MCLAUGHLIN JF HUDGINS L

Citation: Ka. Leppig et al., PATIENT WITH 46,XX,DEL(18)(P11) 46,XX,I(18Q) KARYOTYPE - MOSAICISM FOR 2 DIFFERENT STRUCTURAL CHROMOSOME-ABNORMALITIES, POSSIBLY THE RESULTOF CENTROMERIC MISDIVISION/, American journal of human genetics, 57(4), 1995, pp. 664-664

Authors: KRADJAN WA WITT DM OPHEIM KE WOOD FC

Citation: Wa. Kradjan et al., LACK OF INTERACTION BETWEEN GLIPIZIDE AND COTRIMOXAZOLE, Journal of clinical pharmacology, 34(10), 1994, pp. 997-1002

Authors: LYNN AM NESPECA MK OPHEIM KE SLATTERY JT

Citation: Am. Lynn et al., RESPIRATORY EFFECTS OF INTRAVENOUS MORPHINE INFUSIONS IN NEONATES, INFANTS, AND CHILDREN AFTER CARDIAC-SURGERY, Anesthesia and analgesia, 77(4), 1993, pp. 695-701